| Title |
Vancomycin-induced red man syndrome in pediatric oncology: still an issue?
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, December 2011
|
| DOI | 10.1007/s11096-011-9593-z |
| Pubmed ID | |
| Authors |
Tiene Bauters, Barbara Claus, Petra Schelstraete, Hugo Robays, Yves Benoit, Catharina Dhooge |
| Abstract |
Red man syndrome is a rare but possibly serious adverse reaction during treatment with intravenous vancomycin. It is extremely important that pediatricians, especially in oncology, recognize this reaction and treat it appropriately. Following two case-reports from a pediatric oncology setting, a series of practical recommendations to prevent or handle red man syndrome are described. |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 6% |
| Unknown | 15 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 3 | 19% |
| Other | 2 | 13% |
| Student > Master | 2 | 13% |
| Professor > Associate Professor | 2 | 13% |
| Researcher | 1 | 6% |
| Other | 1 | 6% |
| Unknown | 5 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 25% |
| Business, Management and Accounting | 1 | 6% |
| Unknown | 5 | 31% |